Verrica Pharmaceuticals (VRCA) P/E (2022 - 2026)
Verrica Pharmaceuticals (VRCA) P/E from Sep 30, 2022 to Jul 21, 2026. The TTM Verrica Pharmaceuticals (VRCA) P/E is -5.23. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
P/E
Annual P/E change of Verrica Pharmaceuticals (VRCA)
| Year | P/E | Change |
|---|---|---|
| 2026 | -5.23 | -3.22% |
| 2025 | -5.40 | +1105.85% |
| 2024 | -0.45 | -92.94% |
| 2023 | -6.34 | -100.45% |
| 2022 | 1.41K | N/A |
Comparison Verrica Pharmaceuticals (VRCA) P/E with competitors
Verrica Pharmaceuticals (VRCA) P/E is -5.23.